Cite
Efficacy and safety of molecularly targeted agents and immune checkpoint inhibitors for unresectable or recurrent/metastatic oral cancer in Japan
MLA
Mitsunobu Otsuru, et al. “Efficacy and Safety of Molecularly Targeted Agents and Immune Checkpoint Inhibitors for Unresectable or Recurrent/Metastatic Oral Cancer in Japan.” Journal of Dental Sciences, vol. 19, no. 3, July 2024, pp. 1628–37. EBSCOhost, https://doi.org/10.1016/j.jds.2023.11.024.
APA
Mitsunobu Otsuru, Nobuhiro Yamakawa, Tadaaki Kirita, Shin-ichi Yamada, Hiroshi Kurita, Takuma Kugimoto, Hiroyuki Harada, Takumi Hasegawa, Masaya Akashi, Akinori Takeshita, Narikazu Uzawa, Masahiro Umeda, Souichi Yanamoto, & Tomohiro Yamada. (2024). Efficacy and safety of molecularly targeted agents and immune checkpoint inhibitors for unresectable or recurrent/metastatic oral cancer in Japan. Journal of Dental Sciences, 19(3), 1628–1637. https://doi.org/10.1016/j.jds.2023.11.024
Chicago
Mitsunobu Otsuru, Nobuhiro Yamakawa, Tadaaki Kirita, Shin-ichi Yamada, Hiroshi Kurita, Takuma Kugimoto, Hiroyuki Harada, et al. 2024. “Efficacy and Safety of Molecularly Targeted Agents and Immune Checkpoint Inhibitors for Unresectable or Recurrent/Metastatic Oral Cancer in Japan.” Journal of Dental Sciences 19 (3): 1628–37. doi:10.1016/j.jds.2023.11.024.